Gland Pharma Limited (GLAND) — Cash Flow Quality Index
Gland Pharma Limited (GLAND) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of Rs5.93 Billion exceeds net income of Rs3.99 Billion, indicating high earnings quality where cash backs reported profits. Explore GLAND cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Gland Pharma Limited Cash Flow Quality Index (2017–2026)
Historical Cash Flow Quality Index for Gland Pharma Limited across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Gland Pharma Limited generate cash.
Annual Cash Flow Quality Index for Gland Pharma Limited (2017–2026)
Year-by-year earnings quality comparison for Gland Pharma Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 1.20x | Rs12.31 Billion | Rs10.27 Billion | ▼ -8.5% |
| 2025 | 1.31x | Rs9.15 Billion | Rs6.99 Billion | ▲ +1.5% |
| 2024 | 1.29x | Rs9.97 Billion | Rs7.72 Billion | ▲ +273.9% |
| 2023 | 0.35x | Rs3.64 Billion | Rs10.55 Billion | ▼ -29.4% |
| 2022 | 0.49x | Rs7.91 Billion | Rs16.19 Billion | ▲ +7.8% |
| 2021 | 0.45x | Rs6.05 Billion | Rs13.35 Billion | ▼ -35.8% |
| 2020 | 0.71x | Rs7.01 Billion | Rs9.93 Billion | ▲ +161.5% |
| 2019 | 0.27x | Rs1.85 Billion | Rs6.86 Billion | ▼ -33.0% |
| 2018 | 0.40x | Rs2.02 Billion | Rs5.01 Billion | ▼ -65.0% |
| 2017 | 1.15x | Rs4.76 Billion | Rs4.14 Billion | — |